Kupa, Leonard de Vinci Kanda; Guimarães, Wanderson Vidigal; Silva-Jr, Carlindo Vieira; Sanches-Giraud, Cristina; Gomez, David de Souza; Santos, Silvia Regina Cavani Jorge 
Fonte: Brazilian Journal of Pharmaceutical Sciences. Nome do evento: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Assunto: FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KUPA, Leonard de Vinci Kanda et al. Drug plasma monitoring in critically ill patients receiving a combined therapy vancomycin and beta_lactam for target attainment against nosocomial pathogens. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 02 nov. 2024. , 2016APA
Kupa, L. de V. K., Guimarães, W. V., Silva-Jr, C. V., Sanches-Giraud, C., Gomez, D. de S., & Santos, S. R. C. J. (2016). Drug plasma monitoring in critically ill patients receiving a combined therapy vancomycin and beta_lactam for target attainment against nosocomial pathogens. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Kupa L de VK, Guimarães WV, Silva-Jr CV, Sanches-Giraud C, Gomez D de S, Santos SRCJ. Drug plasma monitoring in critically ill patients receiving a combined therapy vancomycin and beta_lactam for target attainment against nosocomial pathogens. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 11 res. FCF018.[citado 2024 nov. 02 ]Vancouver
Kupa L de VK, Guimarães WV, Silva-Jr CV, Sanches-Giraud C, Gomez D de S, Santos SRCJ. Drug plasma monitoring in critically ill patients receiving a combined therapy vancomycin and beta_lactam for target attainment against nosocomial pathogens. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 11 res. FCF018.[citado 2024 nov. 02 ]
